Morgan Stanley Knock-Out BPMC/ DE000MG2J0U3 /
9/17/2024 9:57:26 PM | Chg.+0.05 | Bid10:00:36 PM | Ask10:00:36 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
1.31EUR | +3.97% | - Bid Size: - |
- Ask Size: - |
Blueprint Medicines ... | 72.9849 USD | 12/31/2078 | Call |
GlobeNewswire
5/27
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Blueprint Medi...
GlobeNewswire
5/23
BPMC INVESTOR ALERT: Andrews & Springer LLC Investigates Blueprint Medicines Corporation
GlobeNewswire
5/20
BPMC Alert: The Law Firm of Andrews & Springer LLC Is Investigating Blueprint Medicines Corporation ...
GlobeNewswire
5/17
Recludix Pharma Presents Data Demonstrating Oral STAT3 Inhibitors Drive Differentiated Efficacy and ...
GlobeNewswire
5/14
Apellis Pharmaceuticals Refinances Existing Debt with Up to $475 Million Non-Dilutive Credit Facilit...
GlobeNewswire
5/2
Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., ...
GlobeNewswire
4/23
Recludix Pharma Announces the Appointment of Dr. Ajay Nirula, Accomplished Pharma Executive and Immu...
GlobeNewswire
11/15/2023
T-Therapeutics raises £48 million Series A for development of next generation TCR therapeutics to tr...
GlobeNewswire
10/31/2023
Recludix Pharma Presents Preclinical Data Demonstrating Strong Efficacy and Favorable Safety Profile...
GlobeNewswire
10/17/2023
Recludix Pharma Presents Preclinical Data from its STAT3 Inhibitor Program at the International Conf...
GlobeNewswire
8/30/2023
Recludix Pharma to Participate in Multiple Investor Conferences in September
GlobeNewswire
8/29/2023
Better Life Partners Raises $26.5 Million in Series B Financing to Amplify and Scale its Hybrid Whol...
GlobeNewswire
3/10/2022
Immuneering Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update...
GlobeNewswire
3/1/2022
Zai Lab Announces Financial Results and Corporate Updates for Twelve Months Ended December 31, 2021
GlobeNewswire
1/18/2022
Immuneering Strengthens Board of Directors with the Appointment of Diana F. Hausman, M.D.